Newsroom | 289143 results

VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital healthcare company focused on leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its majority-owned subsidiary, CYBERWELL (“the Company”), has provided a strategic business update highlighting its unified operating model, proprietary platform capabilities, key certifications, and leadership appointments. An Esc...

BLOOMINGTON, Ill.--(BUSINESS WIRE)--GROWMARK, Inc. has unveiled a new artificial intelligence (AI) agent inside its myFS Agronomy app for the 2026 crop season. This first-of-its-kind innovation combines real-time data analysis with decades of boots-on-the-ground expertise from its crop specialists. The new AI agent delivers faster, more precise agronomic insights, enabling GROWMARK’s FS members and their crop specialists to provide stronger, highly customized recommendations that help farmers o...

EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....

HERNDON, Va.--(BUSINESS WIRE)--Sophia Learning announces a partnership with NurseDash....

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DataVisor, the leading AI-powered fraud and AML platform, today announced Vera, the first suite of conversational AI agents for battling financial crime. Vera redefines how institutions manage risk: teams give instructions in plain language, and AI agents execute them across the entire fraud and AML lifecycle. By replacing time-intensive manual processes and workflows, it introduces a faster, more adaptive, and intelligent operating model built for the de...

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a global leader in providing augmented reality (“AR”) and artificial intelligence (“AI”) Software-as-a-Service (“SaaS”) solutions to beauty and fashion industries, today announced that it plans to release its financial results for the first quarter of 2026 before U.S. markets open on Tuesday, April 28, 2026. About Perfect Corp. Founded in 2015, Perfect Corp. is a leading AI company offering self-developed AI- an...

CHICAGO--(BUSINESS WIRE)--NIQ (NYSE: NIQ) (the “Company”, or “NIQ”), a leading global consumer intelligence company, plans to report its financial results for the first quarter ended March 31, 2026, on Thursday, May 14, 2026. The Company will hold a conference call on the same day at 8:30 a.m. ET to discuss its financial results, business highlights, and certain forward-looking information. The press release and a webcast of the earnings conference call (live and replay) will be available on th...

WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the gross return of the SS&C GlobeOp Hedge Fund Performance Index for March 2026 measured -1.79%. Hedge fund flows as measured by the SS&C GlobeOp Capital Movement Index advanced 0.26% in April. "The 0.26% increase in SS&C GlobeOp's Capital Movement Index for April 2026 was notable, as flows for the period are generally negative from portfolio rebalancing," said Bill Stone, Chairman...

LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health, Inc. (“Valo”), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Dr. Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‑world human data into causal insights that inform drug discovery. Valo aims to improve c...